TELA Bio to Participate in the JMP Securities Life Sciences Conference

MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the Company will participate in the JMP Securities Life Sciences Conference on Monday, May 15th, 2023.

TELA’s management is scheduled to present at 12:00 pm ET on May 15th, 2023. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor ContactGreg Chodaczek347-620-7010[email protected]

You May Also Be Interested In

• L3Harris to Add 50 Jobs in Southwest Ohio with Support of JobsOhio Talent Acquisition Services
• Ducon Infratechnologies Bags Major Order from World’s Largest Aluminium Smelter in India; Positions for Massive Sector Expansion
• HelloNation Article Details Home EV Charger Installation, Featuring Electrical Expert Gerald Talbot